Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials

Por Mbogua, J, Mebrahtu, T, Lindegger, G, Sabrina, W, Anzala, O, Mutua, G, Mpendo, J, Karita, E, Singh, S
Publicado em 2012

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya

Por Mutua, G, Omosa-Manyonyi, G, Park, H, Bergin, P, Laufer, D, Amornkul, PN, Lehrman, J, Fast, P, Gilmour, J, Anzala, O, Farah, B
Publicado em 2012

P06-08. Building an African HIV preventive trial network

Por Price, MA, Allen, S, Anzala, O, Bekker, L, Gilmour, J, Kaleebu, P, Kamali, A, Karita, E, Lakhi, S, Latka, M, Twesigye, R, Sanders, EJ, Amornkul, P, Stevens, G, Thomson, H
Publicado em 2009

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa

Por Ngongo, BP, Priddy, F, Park, H, Bender, B, Fast, P, Anzala, O, Mutua, G, Ruzagira, E, Kamali, A, Karita, E, Mugo, P, Chomba, E, Bekker, L, Roux, S, Nanvubya, A, Mebrahtu, T
Publicado em 2012